Polish Society of Neprology Working Group – Management of autosomal polycystic kidney disease (ADPKD) and other cystic kidney diseases A. Dębska-Ślizień, M. Jankowska, M. Nowicki, M. Klinger, H. Augustyniak-Bartosik, J. Limon, B. Lipska-Ziętkiewicz, M. Matuszewski, J. Różański, E. Szurowska, I. Załuska-Leśniewska, A. Żurowska
The management of Fabry’s disease – Polish Society of Nephrology Board statement M. Nowicki, M. Adamczak, K. Ciechanowski, A. Dębska-Ślizień, M. Durlik, R. Gellert, M. Krajewska, J. Małyszko, A. Masajtis-Zagajewska, A. Oko, K. Pawlaczyk, B. Rutkowski, W. Sułowicz, M. Wajdlich
Urinary kidney injury molecule 1 levels reflect the severity of clinical conditions in newborns treated in intensive care unit
A. Tarko, A. Suchojad, B. Przybył, I. Maruniak-Chudek
Vaccination of dialysis patients
D. Bednarski, A.E. Grzegorzewska
Pulmonary hypertension in hemodialysis patients – a review
A. Pardała, M. Lupa, A. Kolonko
Hypertension pharmacotherapy in kidney transplant recipients
A. Zakrzewska, L. Tylicki, A. Dębska-Ślizień
α-Klotho protein and KL gene variation – their roles in renal diseases and potential application in screening and treatment
K. Rembek, J. Pazik, M. Durlik
Haemodialysis fistula created ipsilaterally to pacemaker leads – the mistake being the source of severe future problems needing complex management
R. Pietura, T. Smyk, Ł. Tułecki, K. Tomkow, B. Zieńczuk, D. Nowsielska, A. Kutarski
55th ERA–EDTA Congress in Copenhagen, 2018 – summary of Polish nephrologists participation
J. Ostrowski
